Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/15/2025

Central Venous Catheter Management and Medication Administration

Central Venous Catheter Placement and Maintenance

  • The subclavian vein is the preferred site for non-tunneled CVCs due to the lowest infection risk, as recommended by the Infectious Diseases Society of America and the Clinical Infectious Diseases society 1
  • The internal jugular vein is the second choice for CVC placement, with a slightly higher infection risk than the subclavian vein, according to the Infectious Diseases Society of America and the Clinical Infectious Diseases society 1
  • The femoral vein should be avoided if possible due to the highest infection risk in adults, as stated by the Infectious Diseases Society of America and the Clinical Infectious Diseases society 1
  • Ultrasound guidance is recommended to reduce mechanical complications during CVC placement, as suggested by the Infectious Diseases Society of America and the Clinical Infectious Diseases society 1
  • Maximal sterile barrier precautions should be implemented during CVC insertion, and the skin should be prepared with 0.5% chlorhexidine preparation with alcohol, as recommended by the Infectious Diseases Society of America and the Clinical Infectious Diseases society 1
  • A CVC with the minimum number of ports or lumens essential for patient management should be used, and the catheter should be removed promptly when no longer necessary, as advised by the Infectious Diseases Society of America and the Clinical Infectious Diseases society 1
  • The catheter insertion site should be evaluated daily for signs of infection, and the central line should be removed as soon as the patient stabilizes and peripheral access becomes adequate, as recommended by the Infectious Diseases Society of America and the Clinical Infectious Diseases society 1

Indications for Central Venous Access

  • Central venous access is indicated when peripheral access is inadequate for the intended therapy, when prolonged intravenous therapy is anticipated, or when specific clinical situations require central venous monitoring, as recommended by the Clinical Nutrition society and the Clinical Infectious Diseases society 2, 1
  • Parenteral nutrition may be needed due to prolonged recovery in patients with severe cases, according to the Clinical Nutrition society 2
  • Vesicant medications require central venous access, as stated by the Clinical Infectious Diseases society 1
  • Long-term IV therapy, expected to exceed 6 days, necessitates central venous access, as recommended by the Clinical Infectious Diseases society 1
  • Hemodialysis and plasmapheresis require high-flow access, typically through a central venous catheter, according to the Clinical Infectious Diseases society 1

Contraindications and Relative Contraindications for Central Venous Catheter Placement

  • The subclavian site is contraindicated in advanced kidney disease due to the risk of stenosis, as stated by the Clinical Infectious Diseases society 1
  • The femoral site is contraindicated in obesity and groin infection due to increased infection risk, according to the Clinical Infectious Diseases society 1
  • Coagulopathy, local infection at insertion site, anatomical distortion, and previous vascular injury or thrombosis at target site are relative contraindications for central venous catheter placement, as noted by the Clinical Infectious Diseases society 1

Catheter Maintenance and Replacement

  • Hand hygiene should be performed before and after palpating, inserting, replacing, accessing, or dressing any catheter, as recommended by the World Health Organization and the Centers for Disease Control and Prevention 3
  • A 0.5% chlorhexidine preparation with alcohol is the preferred skin antiseptic, as recommended by the Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America 1, 3
  • Either sterile gauze or sterile, transparent, semi-permeable dressing should be used, as recommended by the Centers for Disease Control and Prevention and the Society for Healthcare Epidemiology of America 1, 3
  • Dressings should be replaced as follows:
  • Standard administration sets should be replaced no more frequently than every 72 hours, as suggested by the Centers for Disease Control and Prevention and the Society for Healthcare Epidemiology of America 3
  • Tubing used for blood products or lipid emulsions should be replaced within 24 hours, as recommended by the American College of Surgeons and the Infectious Diseases Society of America 3
  • Propofol administration tubing should be replaced every 6-12 hours per manufacturer's recommendation, as suggested by the Society for Healthcare Epidemiology of America 3
  • Catheters should be removed when no longer essential, or when signs of phlebitis or catheter-related infection are present, as recommended by the Centers for Disease Control and Prevention, the Society for Healthcare Epidemiology of America, and the Infectious Diseases Society of America 1, 3

Monitoring and Hemodynamic Assessment

  • Central venous pressure monitoring is used for hemodynamic assessment, as recommended by the Circulation society 4
  • Central venous oxygen saturation (ScvO2) monitoring assesses tissue oxygenation, according to the Circulation society 4
  • Coronary perfusion pressure estimation during cardiopulmonary resuscitation requires central venous access, as stated by the Circulation society 4
  • The most effective strategy to prevent catheter-related complications is to use maximal sterile barrier precautions during insertion, select the appropriate insertion site based on patient factors, and promptly remove catheters when no longer needed, as recommended by the Centers for Disease Control and Prevention and the Society for Healthcare Epidemiology of America 1
  • Therapy duration, solution osmolarity, and medication type are factors to consider when deciding on central venous access, as noted by the Clinical Nutrition and Clinical Infectious Diseases societies 2, 1
  • Hemodynamic monitoring requirements also influence the decision for central venous access, according to the Circulation society 4